Description

• General description: A Certified Solution Standard suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing. Desipramine is a tricyclic antidepressant (TCA) sold under the brand names Norpramin® and Pertofrane. This TCA drug is also a primary active metabolite of imipramine.
• Application: Pharmacological Treatments for Localized Provoked Vulvodynia: Reviews current pharmacological treatments, including tricyclic antidepressants like desipramine hydrochloride, emphasizing their role in managing chronic pain conditions, crucial for ongoing research in neuropharmacology and clinical practice (Bajzak et al., 2023).Desipramine induces anti-inflammatory dorsal root ganglion transcriptional signatures: Highlights the use of desipramine hydrochloride in neurobiological research, specifically its effects on inflammatory responses in nerve injury models, underscoring its significance in neuropharmacological studies (Serafini et al., 2024).Effect of lipid emulsion on neuropsychiatric drug-induced toxicity: Discusses the therapeutic potential of lipid emulsions in managing toxicity caused by drugs, including desipramine hydrochloride, which is essential for improving safety profiles in clinical settings (Hwang and Sohn, 2024).Sustainable beeswax modified cellulose paper for the determination of tricyclic antidepressants: Researches innovative methods for detecting tricyclic antidepressants like desipramine hydrochloride in biofluids, pivotal for advancing forensic and clinical toxicology (González-Bermúdez et al., 2024).Sleep-wake dependent hippocampal regulation of fear memory: Although indirectly related, this study forms part of the broader context of neurological research where desipramine hydrochloride could be used to modulate neurochemical pathways, relevant for understanding sleep-related memory processes (Wen et al., 2024).
• Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany